Dr.med.oezlem Tanriverdi

Dr. Med. Oezlem Tanriverdi is a highly experienced Sr. Global Program Safety Lead at Novartis, specializing in Oncology Early Clinical Development, particularly in CAR-T, KARS, and SHP2 products since May 2017. Responsibilities include serving as an expert safety subject matter expert for due diligence, leading clinical safety discussions at Health Authority Meetings, and authoring critical regulatory documents for clinical development programs. Previous roles include leadership positions at Roche as a Senior Medical Director, overseeing safety and regulatory interactions for Breast Cancer HER2 inhibitors, and extensive experience at Novartis in various drug safety and clinical operations roles. Dr. Tanriverdi holds a Medical Doctor degree from Hacettepe University and an MBA from La Salle University in Istanbul.